Watch tile-shedding private Chinese rocket launch 6 satellites to orbit (video)
The Chinese company LandSpace launched its methane-powered Zhugque-2E rocket on Saturday (May 17), carrying a batch of six satellites to orbit.
Zhugque-2E lifted off Saturday at 12:12 a.m. EDT (0412 GMT; 12:12 p.m. in Beijing) from Site 96 at the Jiuquan Satellite Launch Center's Complex-43, in northwestern China's Gobi Desert. The mission, carried out by LandSpace for commercial satellite maker Changsha Tianyi Space Science and Technology Research Institute, known as Spacety for short, carried six Tianyi satellites into low Earth orbit (LEO).
This was the second launch of LandSpace's Zhugque-2E rocket — the "E" stands for "enhanced", indicating the rocket's extended 13.8-foot (4.2-meter) payload fairing. In total, Zhugque-2E stands 155 feet (47 m) tall. Its first stage is powered by four Tiānquè-12A (TQ-12A) methalox-powered engines, with a vacuum-optimized TQ-15A engine powering the upper stage.
The six satellites, numbered Tianyi 29, 34, 35, 42, 45 and 46, will join a constellation of diverse Earth-observation spacecraft operated by Spacety in LEO.
The batch includes two optical remote sensing satellites, Tianyi 29 and 35; three space science experiment satellites, Tianyi 24, 45 and 46; and one remote-sensing synthetic aperture radar satellite, Tianyi 42.
Related stories:
— US and China need a space hotline for orbital emergencies, experts say
— Watch China's private Ceres-1 rocket launch 4 satellites from a ship at sea (video)
— Watch China launch Smart Dragon-3 rocket from the sea (video)
This was the 27th orbital launch from China so far this year, with more than half a dozen lifting off in the month of May alone. Just two days following the LandSpace launch, another Chinese company, Galactic Energy, launched its solid-propellant Ceres-1 rocket from a ship at sea.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
43 minutes ago
- Yahoo
New Peer-Reviewed Study in New England Journal of Medicine Catalyst Finds Twin Health's AI Precision Treatment Significantly Improves Outcomes in Patients with Type 2 Diabetes and Reduces Reliance on Costly Medications, Including GLP-1s
Cleveland Clinic-led study finds Twin Health's precision AI and hyper-personalized care outperforms standard diabetes treatment—reducing A1C, unhealthy weight, and medication use MOUNTAIN VIEW, Calif., Aug. 20, 2025 /PRNewswire/ -- Today, Twin Health announced the publication of results from a Cleveland Clinic-led study in the New England Journal of Medicine Catalyst, evaluating its Twin Precision Treatment for the management of type 2 diabetes. The program features technology-driven interventions that leverage artificial intelligence to deliver personalized insights and lifestyle recommendations aimed at improving glycemic control and metabolic health in adults with type 2 diabetes. The findings, published today, showed that 71% of study participants using the Twin Precision Treatment system met the primary endpoint of achieving an A1C below 6.5% while eliminating most blood sugar-lowering medications, including glucagon-like peptide-1 (GLP-1) receptor agonists, sodium glucose cotransporter-2 (SGLT-2) inhibitors, dipeptidyl peptidase-4 (DPP-4) inhibitors, and insulin. Type 2 diabetes affects nearly 1 in 10 Americans, and prolonged elevated blood sugar levels increase the risk of serious complications like heart disease, kidney failure, and stroke. Twin Precision Treatment System Uses Artificial Intelligence, Machine Learning and Wearable Sensors for Sustainable Results Developed by Twin Health, the Twin Precision Treatment combines digital twin AI with personalized clinical care, including licensed providers, nurses, and coaches. Using data from wearable sensors, the system continuously tracks real-time health metrics such as blood glucose levels, weight, blood pressure, stress, physical activity, and sleep. Users access these insights through a smartphone app, offering personalized nutrition and exercise guidance, encouraging patients to achieve their goals and sustainable health improvements. The specific app-generated dietary recommendations were based on AI-enabled predictions of each patient's blood glucose responses to specific meals. "The study demonstrates that AI-driven precision medicine is the key to metabolic healing," said Dr. Lisa Shah, chief medical officer and executive vice president of Twin Health. "We're committed to our mission of producing real results for real people. This study is an important milestone on that journey and a glimpse into what's ahead for the future of metabolic care." Kevin M. Pantalone, D.O., Director of Diabetes Initiatives at the Cleveland Clinic and a professor of medicine at the Cleveland Clinic Lerner College of Medicine, served as the primary investigator for this study. For the clinical trial (NCT05181449), researchers aimed to determine whether Twin Health's Twin Precision Treatment system could help individuals with type 2 diabetes, managed in a primary care setting, achieve their blood sugar goals while also eliminating glucose-lowering medications. "In routine clinical practice, type 2 diabetes is often treated with a one-size-fits-all approach where individuals are prescribed medications and told to 'watch their diet and stay active," said Dr. Pantalone. "Our study demonstrated the AI-enabled system of sensors to understand each patient's unique metabolic profile, and AI-enabled human care team coaching facilitated significant improvements in glycemic control, weight loss, and quality of life versus usual care, while allowing marked de-escalation of glucose-lowering medications. Interventions like this system can help patients make informed, lasting lifestyle changes to control their blood sugar and sustain weight loss." Dr. Pantalone collaborated with a team of 13 primary care physicians to recruit 150 patients from the Cleveland Clinic Twinsburg Family Health Center located in Twinsburg, Ohio. Of these, 100 were assigned to the Twin Precision Treatment group and 50 to the standard of care group. On average, patients were 58.5 years old, had been living with type 2 diabetes for about nine years, and presented with a mean body mass index (BMI) of 35.1 and an average A1C level of 7.2%. The primary endpoint was to see how many participants reached an A1C below 6.5% after 12 months without needing any glucose-lowering medications except for metformin, a common low-cost diabetes medication. After one year, a majority of study participants in the Twin intervention group achieved an A1C below 6.5% After one year, 71% of participants enrolled in the intervention group lowered their A1C levels below the 6.5% threshold, while taking only metformin. By comparison, only 2.4% of participants receiving standard care achieved the same result. Participants in the Twin intervention group also lost more weight (8.6% vs 4.6% of body weight) while significantly reducing their reliance on medications: GLP-1 Receptor Agonist medication use decreased from 41% to 6% among participants SGLT-2 Inhibitor use decreased from 27% to 1% of participants Dipeptidyl peptidase-4 (DPP-4) inhibitor use decreased from 33% to 3% in participants Insulin use decreased from 24% to 13% among participants The quality of life scores and treatment satisfaction were notably better for those using the Twin Precision Treatment, highlighting its potential as a highly effective and sustainable option for diabetes management. Real-World Reduction in GLP-1 UseIn the Cleveland Clinic-led study, 85% of participants in the Twin Health program eliminated GLP-1s, demonstrating that many individuals can sustain clinical goals without long-term dependence. Translating Clinical Success into Cost SavingsTwin Health is proven effective for diabetes, weight loss and metabolic health comorbidities, including hypertension. Twin Health's real-world results echo the RCT findings, delivering over $8,000 in average first-year savings per member. These savings result from reducing reliance on high-cost medications, such as GLP-1s, and avoiding unnecessary care utilization, making Twin a scalable and cost-effective solution for employers and health plans seeking to address the growing burden of metabolic disease. About Twin HealthTwin Health's AI digital twin technology creates a real-time model of each individual's unique metabolism using data from smart devices, lab results, and meal logs. This model provides personalized guidance on nutrition, activity, sleep, and more, supported by a compassionate clinical team. Twin's AI digital twin and human care work in synergy, providing a continuous new standard of care for metabolic health. For employers and health plans, Twin delivers $8.0K+ in annualized savings per member by safely reducing reliance on high-cost medications and lowering avoidable medical utilization. Twin's clinical results for diabetes, weight loss and metabolic health co-morbidities, including hypertension, are peer-reviewed and published in top journals, including the New England Journal of Medicine Catalyst and those of the American Heart Association, American Diabetes Association, and American College of Cardiology. Learn more at Press ContactAlex McKechnieAOX3 for Twin View original content to download multimedia: SOURCE Twin Health Sign in to access your portfolio
Yahoo
5 hours ago
- Yahoo
Would you board a spacecraft that takes 400 years to reach Alpha Centauri?
When you buy through links on our articles, Future and its syndication partners may earn a commission. Imagine leaving Earth forever and boarding a spaceship designed to carry you and thousands of others on a one-way trip to the nearest star system, Alpha Centauri — a journey that could take 400 years. This is the bold vision behind Chrysalis, a hypothetical spacecraft that could transport 2,400 people over 25 trillion miles (40 trillion kilometers) to the exoplanet Proxima Centauri b. The project won first place in the Project Hyperion Design Competition on July 23, a contest among engineers to design a hypothetical multigenerational spacecraft built for long-duration interstellar travel and capable of sustaining a closed society over centuries. Although this plan is purely hypothetical, it leaves a pressing question for us all: Would you be willing to join this extraordinary journey? Take our poll and let us know what you think in the comments below. Related stories —'The most significant JWST finding to date': James Webb spots — then loses — a giant planet orbiting in the habitable zone of our closest sun-like star —Cosmic rays could help support alien life on worlds outside the 'Goldilocks zone' —The final 'planet parade' of 2025 rises Sunday. Here's how to see the full 6-planet show. Solve the daily Crossword
Washington Post
12 hours ago
- Washington Post
The future of home-building is here. And we're behind.
Andrés Clarens is a professor of engineering at the University of Virginia and a former assistant director for industrial decarbonization in the White House Office of Science and Technology. Every home starts with basic components: concrete for foundations, steel or wood for framing, glass for windows and chemicals for insulation and finishes. These can account for half of total construction cost, making them a major driver of housing affordability and availability. And just as the United States needs to build millions of new homes, we are leaving it to Chinese laboratories to design the materials for them. These core ingredients are an often overlooked aspect of our housing shortage. They are expensive, energy-intensive and traded internationally much more than they were a generation ago. We need better, faster and cheaper domestic production of construction materials. A collection of 24 projects supported by the Energy Department's Industrial Demonstrations Program were developing technologies to enable that. In May, the Trump administration revoked funding for them, citing a lack of alignment with its priorities. The U.S. materials innovation ecosystem is among the best in the world, but it lags at commercializing discoveries. Two years ago, the demonstrations program was expanded to recover that gap by giving companies grant support to deploy and scale its first-of-a-kind technology. The canceled grants supported projects that were on track to reshape their respective industries, including Sublime Systems, which is developing cement production methods that circumvent the sector's reliance on coal, reducing costs while eliminating cement's carbon pollution problem. Chemical company Eastman's molecular recycling facility is transforming plastic waste into resins for siding, insulation and piping at lower costs. American Ductile Iron Pipe was developing cheaper ways to make ductile iron pipe to address aging water infrastructure in American homes. Technip and LanzaTech are focused on producing ethylene from industrial waste gas, enabling production of coatings, insulation and plumbing components. The reversal of grant funding for these innovations strikes at an inopportune time. Demand remains high: By some estimates, a single family home requires 50 tons of concrete, 10 tons of steel and 2 tons of chemical products. But in the past two decades, the United States has lost much of its domestic production capacity. Almost all domestic aluminum production has migrated to China's subsidized electricity. Cement, which used to be produced near most American cities, is increasingly imported. Glass production has consolidated around lower-cost international competitors. This exodus leaves American home builders dependent on imported materials subject to price volatility, supply chain disruptions and geopolitical tensions. While American policymakers implement shortsighted funding cuts, China focuses on technological leadership in new materials through its $300 billion 'Made in China 2025' industrial plan. Chinese companies already produce over half of the world's cement and are set to become the leading producer of bio-based chemicals. The country controls over half of global aluminum production, most rare earth elements used in advanced materials and growing market shares in specialized construction chemicals. Meanwhile, American alternatives remain trapped in laboratory settings without the ability to demonstrate their viability at scale. The productivity crisis in construction labor compounds these material challenges. Construction worker productivity has been steadily dropping for nearly 50 years while other industries have seen dramatic gains through automation and improved processes. The construction industry's resistance to technological adoption, fragmented structure and reliance on traditional methods has put us well behind China and the European Union in construction labor productivity. That's why our housing shortage cannot be solved with incremental improvement to existing materials and methods. Advanced materials that simplify assembly processes and reduce the specialized skills required for installation could help reverse this productivity decline. Imagine concrete that can also store energy and eliminates your power bill. Structural materials that are stronger than steel but lighter than aluminum, enabling faster assembly with smaller crews. Building systems that integrate recycled insulation, structure and finish materials into single components that dramatically reduce construction complexity. These innovations are emerging from research laboratories around the world, including many American institutions. While some might succeed without government support, the retreat in Industrial Demonstrations Program funding makes it less likely that homegrown ideas will make it to market. Supporting basic research only to allow the technology to be commercialized overseas is a poor investment of taxpayer dollars. Despite the loss of grant funding, the window to establish American leadership in materials development has not closed. Congress, for instance, could redirect canceled demonstration funding toward a comprehensive materials innovation initiative focused on housing construction. To be most effective, investments should prioritize technologies that can simultaneously achieve three objectives: reduce construction costs and pollution, accelerate building timelines, and improve housing quality. This moment represents a strategic inflection point. Global materials markets are already shifting away from traditional materials. America can either lead this transformation, or we could license the technologies from China.
